Apolipoprotein(a) size polymorphism in young adults with ischemic stroke (Q47272541)

13 January 2018

title

Apolipoprotein(a) size polymorphism in young adults with ischemic stroke (English)

1 reference

13 January 2018

author name string

Peynet J

1

1 reference

13 January 2018

Beaudeux JL

2

1 reference

13 January 2018

Woimant F

3

1 reference

13 January 2018

Flourié F

4

1 reference

13 January 2018

Giraudeaux V

5

1 reference

13 January 2018

Vicaut E

6

1 reference

13 January 2018

Launay JM

7

1 reference

13 January 2018

publication date

1 January 1999

1 reference

13 January 2018

published in

Atherosclerosis

1 reference

13 January 2018

volume

142

1 reference

13 January 2018

issue

1

1 reference

13 January 2018

page(s)

233-239

1 reference

13 January 2018

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Molecular definition of the extreme size polymorphism in apolipoprotein(a).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

A potential basis for the thrombotic risks associated with lipoprotein(a).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein(a) in patients with carotid atherosclerosis and ischemic cerebrovascular disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein[a] as a risk factor for preclinical atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Plasma lipids and lipoproteins in subtypes of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein(a) and ischemic cerebrovascular disease in young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Case-control study of serum lipoprotein(a) and apolipoproteins A-I and B in stroke in the young

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Plasma lipoprotein(a) levels in subjects attending a metabolic ward. Discrimination between individuals with and without a history of ischemic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein(a) is an independent risk factor for multiple cerebral infarctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Apo(a) isoforms predict risk for coronary heart disease. A study in six populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

The relative electrophoretic mobility of apo(a) isoforms depends on the gel system: proposal of a nomenclature for apo(a) phenotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein(a) in patients with acute cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Hypervariable polymorphism of APO(a) in blacks and whites as reflected by phenotyping.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction. The EARS Study. European Atherosclerosis Research Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Sequence microheterogeneity in apolipoprotein(a) gene repeats and the relationship to plasma Lp(a) levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Transient changes of serum lipoprotein(a) as an acute phase protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: the ARIC Study. Atherosclerosis Risk in Communities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900232-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(98)00232-9

1 reference

13 January 2018

1 reference

13 January 2018